Pyrazolam (SH-I-04)is a benzodiazepine derivative originally developed by a team led by Leo Sternbach at Hoffman-La Roche in the 1970s, and subsequently "rediscovered" and sold as a designer drug starting in 2012. Pyrazolam has structural similarities t

XANAX is a triazolobenzodiazepine indicated for the treatment of anxiety and panic disorders. It is mainly metabolized by CYP3As and so is contraindicated with CYP3A inhibitors like ketoconazole and itraconazole. Benzodiazepine treatment should be stopped

Etizolam is a thienodiazepine which is chemically related to benzodiazepine (BDZ) drug class; it differs from BDZs in having a benzene ring replaced with a thiophene ring. It is an agonist at GABA-A receptors and possesses amnesic, anxiolytic, anticonvuls

Meclonazepam was discovered by a team at Hoffmann-La Roche in the 1970s and is a drug which is a benzodiazepine derivative similar in structure to clonazepam It has sedative and anxiolytic actions like those of other benzodiazepines,and also has anti-para

BROMAZOLAM is a benzodiazepine derivative. It possesses anxiolytic, anticonvulsant, sedative, and antidepressant properties, it was never FDA approved and was never available to the public. This product is intended for laboratory research purposes only

Ro5-4864(4'-chlorodiazepam) is a drug which is a benzodiazepine derivative of diazepam. However unlike most benzodiazepine derivatives, Ro5-4864 lacks affinity for GABAA receptors and lacks typical benzodiazepine effects,instead being sedative yet also co

3-HYDROXYPHENAZEPAM is a benzodiazepine with hypnotic, sedative, anxiolytic, and anticonvulsant properties, Relative to phenazepam, 3-hydroxyphenazepam has diminished myorelaxant properties, but is about equivalent in most other regards.Like other benzodi